Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
metroNIDAZOLE
metroNIDAZOLE
- Formulary metroNIDAZOLE Formulary
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Flagyl 375 | CAPSULE, ORAL | 375 mg | ||||
| Flagyl | KIT, ORAL | 50 mg/mL | ||||
| Flagyl I.V. | SOLUTION, INTRAVENOUS | 500 mg/100 mL | ||||
| Flagyl ER | TABLET, EXTENDED RELEASE, ORAL | 750 mg | ||||
| Flagyl, Metryl, Protostat | TABLET, ORAL | 250 mg, 500 mg |
Last updated: Mar. 30, 2022
- Black Box Warning: Carcinogenicity
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
metroNIDAZOLE (Flagyl 375)
375 mg oral tablet
metroNIDAZOLE (Flagyl)
500 mg oral tablet
Give at same dosing Interval
metroNIDAZOLE ER (Flagyl ER)
750 mg extended release oral tablet
metroNIDAZOLE (Flagyl)
250 mg oral tablet Q8hrs
Use 250 mg tablets Q8hrs for 750 mg ER tab once daily
Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines
metroNIDAZOLE q6h regimens may be automatically changed to q8h.